期刊文献+

非肌层浸润性膀胱癌术后再电切的临床分析 被引量:7

Clinical analysis of the secondary transurethral resection in the treatment of non-muscle invasive bladdercancer
原文传递
导出
摘要 目的探讨二次电切术对非肌层浸润性膀胱癌复发的影响。方法186例非肌层浸润性膀胱癌患者随机分为对照组和实验组,两组均采用经尿道电切术(TURBT)进行治疗,实验组在术后4周进行二次电切术,比较两组患者复发情况。结果实验组复发率13.8%,低于对照组37.O%(X2=13.17,P〈O.05)。原部位复发例数低于对照组(X2=8.35,P〈O.05)。结论二次电切术对减少非肌层浸润性膀胱癌的复发有一定的积极作用。 Objective To investigate the effect of the secondary transurethral resection in the treatment of non-muscle invasive bladder cancer(NMIBC). Methods 186 cases with NMIBC were randomly divided into control and experimental groups, both groups were treated by transurethral resection of bladder tumor(TURBT), and experimental group received the secondary TURBT after 4 weeks of the first TURBT. The recurrences of two groups were compared. Results The recurrence rate was significantly lower in experimental group than in the control group(13.8% vs. 37.0% ,X2 = 13.17, P〈0.05). The recurrence number of the original site was significantly less in experimental group than in the control group(X2 =8.35, P〈0.05). Conclusions The secondary TURBT plays a positive role in NMIBC recurrence.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2014年第2期183-185,共3页 Chinese Journal of Geriatrics
关键词 膀胱肿瘤 经尿道前列腺切除术 复发 Urinary bladder neoplasms Transurethral resection of prostate Recurrence
  • 相关文献

参考文献10

二级参考文献51

共引文献47

同被引文献55

  • 1Lightfoot A J, Rosevear HM, Nepple KG, et al. Role of routine tran- surethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer[ J ]. Int J Uro1,2012,19 ( 11 ) :988 - 993.
  • 2Stein JP. Indications for early cystectomy [ J ]. Urology, 2003,62 (4) :591 -595.
  • 3Dalbagni G, Vora K, Kaag M, et al. Clinical outcome in a contem- porary series of restaged patients with clinical T1 bladder cancer [J~. Eur Urol,2009,56(6) :903 -910.
  • 4Divrik RT, Sahin AF, Yildirim U, et al. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pTlurothelial carcinoma with respect to recur- rence, progression rate, and disease-specific survival : a prospective- randomised clinical trial[J]. Eur Urol,2010,58(2) :185 -190.
  • 5Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines on non- muscle-invasive urothelial carcinoma of the bladder: update 2013 [ J ]. Eur Uro1,2013,64 (4) :639 - 653.
  • 6Babjum, Ostedine W, Sylvesterr, et al. EAU guidelines on non- muscle - invasive umthelial carcinoma Of the bladder [J]. Enr Urol,2011,59:997 - 1 008.
  • 7Msriappan P, Zaehou A, Grigor K . Detrusor muscle in the first, apparently complete transnrethral resection of bladder tu- mourspecimen is a surrogate marker of resection quality, pre- dicts risk of early recurrence, and is dependent on operator ex- perience[ J]. Eur Urol,2010,57:843 - 849.
  • 8Babjuk M, Oosterlinck W, Sylvester R,et al. EAU guidelines on nonmuscle-invasive urothelial carcinoma of the bladder, the 2011 update [J]. European Urology, 2011,59(6):997-1008.
  • 9Chen JX,Deng N,Chen X,et al. A novel molecular grading model:Combination of Ki67 and VEGF in predicting tumor recurrence and progression in non-invasive urothelial bladder cancer[J]. Asian Pac J Cancer Prev,2012, 13 (5) :2229-2234.
  • 10Herr HW. Role of reresection in non-muscle-invasive bladder cancer [J]. Scientific World J, 2011,3 ( 11 ) : 283 - 288.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部